Luisa Gregori

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi A sensitive and quantitative assay for normal PrP in plasma
    Luisa Gregori
    Veterans Affairs Medical Center and University of Maryland, Baltimore, MD 21201, United States
    J Virol Methods 149:251-9. 2008
  2. ncbi Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands
    Luisa Gregori
    Veterans Affairs Maryland Health Care System, VA Medical Center, University of Maryland, Baltimore, Maryland 21201, USA
    Transfusion 46:1152-61. 2006
  3. ncbi Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins
    Luisa Gregori
    Veterans Affairs Maryland Health Care System, VA Medical Center, University of Maryland at Baltimore, MD 21201, USA
    Lancet 368:2226-30. 2006

Collaborators

Detail Information

Publications3

  1. ncbi A sensitive and quantitative assay for normal PrP in plasma
    Luisa Gregori
    Veterans Affairs Medical Center and University of Maryland, Baltimore, MD 21201, United States
    J Virol Methods 149:251-9. 2008
    ..This is a novel and sensitive assay for the detection of PrP in plasma that could be developed into a platform for a plasma-based TSE test...
  2. ncbi Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands
    Luisa Gregori
    Veterans Affairs Maryland Health Care System, VA Medical Center, University of Maryland, Baltimore, Maryland 21201, USA
    Transfusion 46:1152-61. 2006
    ..A follow-up experiment is in progress to test whether endogenous blood-borne infectivity is also reduced...
  3. ncbi Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins
    Luisa Gregori
    Veterans Affairs Maryland Health Care System, VA Medical Center, University of Maryland at Baltimore, MD 21201, USA
    Lancet 368:2226-30. 2006
    ..INTERPRETATION: TSE affinity ligands, when incorporated into appropriate devices, can be used to mitigate the risks from TSE-infected blood, blood products, and other materials exposed to TSE infectivity...